Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Ohlmann

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Der Urologe. Ausg. A|October 7, 2017
[Patients with metastatic prostate cancer : Recommendations for primary hormonal or chemohormonal therapy]C-H Ohlmann
Aktuelle Urologie|April 13, 2013
[Bone metastases]C-H Ohlmann
Der Urologe. Ausg. A|March 21, 2009
[Prognostic factors for survival of patients with metastatic renal cell carcinoma]C-H Ohlmann
Der Urologe. Ausg. A|September 20, 2015
[Chemotherapy of prostate cancer]C-H Ohlmann
Der Urologe. Ausg. A|March 2, 2017
[Antihormonal therapy in prostate cancer : Side effects]C H Ohlmann, P Thelen
Der Urologe. Ausg. A|October 21, 2005
[Treatment options for hormone-refractory prostate cancer]A Heidenreich, C H Ohlmann
Aktuelle Urologie|July 8, 2005
[The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer]A Heidenreich, C H Ohlmann
Der Urologe. Ausg. A|April 11, 2020
[Combination therapy for metastatic hormone-sensitive prostate cancer: What? When? For whom?]C Thomas, C-H Ohlmann
Der Urologe. Ausg. A|September 3, 2010
[Diagnostic work-up and treatment of bladder cancer: current developments]C-H Ohlmann, M Stöckle
Der Urologe. Ausg. A|November 11, 2009
[What comes after docetaxel?]C-H Ohlmann, M Stöckle
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Der Urologe. Ausg. A|October 7, 2017
[Patients with metastatic prostate cancer : Recommendations for primary hormonal or chemohormonal therapy]C-H Ohlmann
Aktuelle Urologie|April 13, 2013
[Bone metastases]C-H Ohlmann
Der Urologe. Ausg. A|March 21, 2009
[Prognostic factors for survival of patients with metastatic renal cell carcinoma]C-H Ohlmann
Der Urologe. Ausg. A|September 20, 2015
[Chemotherapy of prostate cancer]C-H Ohlmann
Der Urologe. Ausg. A|March 2, 2017
[Antihormonal therapy in prostate cancer : Side effects]C H Ohlmann, P Thelen
Der Urologe. Ausg. A|October 21, 2005
[Treatment options for hormone-refractory prostate cancer]A Heidenreich, C H Ohlmann
Aktuelle Urologie|July 8, 2005
[The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer]A Heidenreich, C H Ohlmann
Der Urologe. Ausg. A|April 11, 2020
[Combination therapy for metastatic hormone-sensitive prostate cancer: What? When? For whom?]C Thomas, C-H Ohlmann
Der Urologe. Ausg. A|September 3, 2010
[Diagnostic work-up and treatment of bladder cancer: current developments]C-H Ohlmann, M Stöckle
Der Urologe. Ausg. A|November 11, 2009
[What comes after docetaxel?]C-H Ohlmann, M Stöckle
Pageof 4